Completed PHASE4 INTERVENTIONAL 1-arm
NCT02372357
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based in Body Surface Area
Sponsor: Institutul Clinic Fundeni
Conditions
Hematological Malignancy
Interventions
Blood sampling Posaconazole prophylaxis 120 mg/m² tid
Updated 1 time since 2024 Last updated: Mar 2, 2015 Started: Feb 29, 2012 Primary completion: Aug 31, 2014 Completion: Oct 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT02372357, this PHASE4 trial focuses on Hematological Malignancy and remains completed. Sponsored by Institutul Clinic Fundeni, it has been updated 1 time since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Institutul Clinic Fundeni
- Universitaire Ziekenhuizen KU Leuven
Data source: Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .